Revolution Medicines FDA Accepts Daraxonrasib NDA for Pancreatic Cancer
Revolution Medicines, Redwood City, Calif., July 22, 2026 Revolution Medicines announced that the U.S. Food and Drug Administration (FDA)...
Cancer Treatment
Advertisement
Alpha Tau Medical Ltd. Reports Positive Head and Neck Cancer Results
JERUSALEM, July 21, 2026 Alpha Tau Medical Ltd. announced positive clinical study results evaluating its Alpha DaRT® (Diffusing Alpha-emitters...
Immunome Doses First Patient in Phase 1 IM-3050 Radioligand Therapy Trial
BOTHELL, Wash., July 20, 2026 Immunome, Inc. (Nasdaq: IMNM) announced that the first patient has been dosed in the...
Ananda Pharma Doses First Patient in Phase 2 CIPN Trial
UNITED KINGDOM, June 17, 2026 Ananda Pharma Limited has announced that the first patient has been dosed in the...
Telix Opens Australia’s First Integrated Radiopharmaceutical Facility for Cancer Care
MELBOURNE, Australia & INDIANAPOLIS, Ind., July 16, 2026 Telix has officially opened Telix Manufacturing Solutions North Melbourne (TMSNM), Australia’s...
Advertisements
Montefiore Einstein Expands CGM Use to Improve Diabetes Care
BRONX, New York, July 6, 2026 Montefiore Einstein investigators have published new research demonstrating that expanding the use of...
AMO Pharma Aligns Global Trial Plan for AMO-02 in cDM1
LONDON, United Kingdom, July 6, 2026 AMO Pharma Limited has announced a significant regulatory milestone for its investigational therapy...
AbbVie Wins EU Approval for TEPKINLY in Follicular Lymphoma
NORTH CHICAGO, Illinois, July 6, 2026 AbbVie has announced that the European Commission (EC) has granted marketing authorization for...
Movmedix Enters U.S. Market with FDA-Cleared LARS® Technology
ARC-SUR-TILLE, France, July 6, 2026 Movmedix, the French orthopedic medical technology company behind the globally recognized LARS® synthetic ligament...
IceCure Expands ProSense Cryoablation in Brazil After FDA Clearance
CAESAREA, Israel, July 6, 2026 IceCure Medical Ltd. has announced accelerating commercial adoption of its ProSense™ cryoablation system in...
Advertisement
